BSL — Raffles Medical Balance Sheet
0.000.00%
- SG$1.85bn
- SG$1.74bn
- SG$751.56m
- 95
- 40
- 85
- 89
Annual balance sheet for Raffles Medical, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 203 | 265 | 253 | 344 | 344 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 113 | 161 | 228 | 129 | 162 |
| Total Inventory | |||||
| Total Current Assets | 331 | 439 | 494 | 485 | 516 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 740 | 797 | 739 | 768 | 748 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,404 | 1,545 | 1,532 | 1,528 | 1,531 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 280 | 417 | 363 | 379 | 382 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 505 | 584 | 519 | 500 | 481 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 899 | 961 | 1,012 | 1,028 | 1,050 |
| Total Liabilities & Shareholders' Equity | 1,404 | 1,545 | 1,532 | 1,528 | 1,531 |
| Total Common Shares Outstanding |